BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Pharmaceutical and Waste Management Developments Dominate Market Focus
Pharmaceutical and Waste Management Developments Dominate Market Focus
7
3
BTCCSquare news:
Alembic Pharmaceuticals secured final FDA approval for its Tretinoin Cream USP, 0.025%, a therapeutic equivalent to Bausch Health's Retin-A Cream. The topical treatment targets acne vulgaris, marking a significant milestone for the company's US market expansion.
Aurobindo Pharma anticipates its China facility will reach EBITDA breakeven by Q3 FY26. The $145 million investment, operational since November 2024, is currently scaling production with an initial capacity of 2 billion units. CFO Santhanam Subramanian confirmed revenue contributions will begin imminently.
EMS secured a Rs 104.06 crore contract from UP Jal Nigam for waste management services. The 24-month project underscores growing infrastructure spending in urban utilities.
By:
